BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1371 related articles for article (PubMed ID: 29136014)

  • 21. Early mortality among adults accessing a community-based antiretroviral service in South Africa: implications for programme design.
    Lawn SD; Myer L; Orrell C; Bekker LG; Wood R
    AIDS; 2005 Dec; 19(18):2141-8. PubMed ID: 16284464
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HIV treatment eligibility expansion and timely antiretroviral treatment initiation following enrollment in HIV care: A metaregression analysis of programmatic data from 22 countries.
    Tymejczyk O; Brazier E; Yiannoutsos C; Wools-Kaloustian K; Althoff K; Crabtree-Ramírez B; Van Nguyen K; Zaniewski E; Dabis F; Sinayobye JD; Anderegg N; Ford N; Wikramanayake R; Nash D;
    PLoS Med; 2018 Mar; 15(3):e1002534. PubMed ID: 29570723
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Population-wide differentials in HIV service access and outcomes in the Western Cape for men as compared to women, South Africa: 2008 to 2018: a cohort analysis.
    Osler M; Cornell M; Ford N; Hilderbrand K; Goemaere E; Boulle A
    J Int AIDS Soc; 2020 Jun; 23 Suppl 2(Suppl 2):e25530. PubMed ID: 32589367
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of nurse-delivered community-based CD4 services on facilitating pre-ART care in rural South Africa.
    Kompala T; Moll AP; Mtungwa N; Brooks RP; Friedland GH; Shenoi SV
    BMC Health Serv Res; 2016 Aug; 16(a):374. PubMed ID: 27515233
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact on ART initiation of point-of-care CD4 testing at HIV diagnosis among HIV-positive youth in Khayelitsha, South Africa.
    Patten GE; Wilkinson L; Conradie K; Isaakidis P; Harries AD; Edginton ME; De Azevedo V; van Cutsem G
    J Int AIDS Soc; 2013 Jul; 16(1):18518. PubMed ID: 23830642
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Delays in starting antiretroviral therapy in patients with HIV-associated tuberculosis accessing non-integrated clinical services in a South African township.
    Lawn SD; Campbell L; Kaplan R; Little F; Morrow C; Wood R;
    BMC Infect Dis; 2011 Sep; 11():258. PubMed ID: 21957868
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immediate Antiretroviral Therapy Decreases Mortality Among Patients With High CD4 Counts in China: A Nationwide, Retrospective Cohort Study.
    Zhao Y; Wu Z; McGoogan JM; Shi CX; Li A; Dou Z; Ma Y; Qin Q; Brookmeyer R; Detels R; Montaner JSG
    Clin Infect Dis; 2018 Feb; 66(5):727-734. PubMed ID: 29069362
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Longitudinal analysis of sociodemographic, clinical and therapeutic factors of HIV-infected individuals in Kinshasa at antiretroviral therapy initiation during 2006-2017.
    Ngongo NM; Darcis G; Nanituna HS; Mambimbi MM; Maes N; Mashi ML; Bepouka Izizag B; Moutschen M; Lepira Bompeka F
    PLoS One; 2021; 16(11):e0259073. PubMed ID: 34739506
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mortality in patients with HIV-1 infection starting antiretroviral therapy in South Africa, Europe, or North America: a collaborative analysis of prospective studies.
    Boulle A; Schomaker M; May MT; Hogg RS; Shepherd BE; Monge S; Keiser O; Lampe FC; Giddy J; Ndirangu J; Garone D; Fox M; Ingle SM; Reiss P; Dabis F; Costagliola D; Castagna A; Ehren K; Campbell C; Gill MJ; Saag M; Justice AC; Guest J; Crane HM; Egger M; Sterne JA
    PLoS Med; 2014 Sep; 11(9):e1001718. PubMed ID: 25203931
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suboptimal immune recovery during antiretroviral therapy with sustained HIV suppression in sub-Saharan Africa.
    Kroeze S; Ondoa P; Kityo CM; Siwale M; Akanmu S; Wellington M; de Jager M; Ive P; Mandaliya K; Stevens W; Boender TS; de Pundert ME; Sigaloff KCE; Reiss P; Wit FWNM; Rinke de Wit TF; Hamers RL
    AIDS; 2018 May; 32(8):1043-1051. PubMed ID: 29547445
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD4 count recovery and associated factors among individuals enrolled in the South African antiretroviral therapy programme: An analysis of national laboratory based data.
    Kufa T; Shubber Z; MacLeod W; Takuva S; Carmona S; Bor J; Gorgens M; Pillay Y; Puren A; Eaton JW; Fraser-Hurt N
    PLoS One; 2019; 14(5):e0217742. PubMed ID: 31150489
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative effectiveness of immediate antiretroviral therapy versus CD4-based initiation in HIV-positive individuals in high-income countries: observational cohort study.
    Lodi S; Phillips A; Logan R; Olson A; Costagliola D; Abgrall S; van Sighem A; Reiss P; Miró JM; Ferrer E; Justice A; Gandhi N; Bucher HC; Furrer H; Moreno S; Monge S; Touloumi G; Pantazis N; Sterne J; Young JG; Meyer L; Seng R; Dabis F; Vandehende MA; Pérez-Hoyos S; Jarrín I; Jose S; Sabin C; Hernán MA;
    Lancet HIV; 2015 Aug; 2(8):e335-43. PubMed ID: 26423376
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gender differences in survival among adult patients starting antiretroviral therapy in South Africa: a multicentre cohort study.
    Cornell M; Schomaker M; Garone DB; Giddy J; Hoffmann CJ; Lessells R; Maskew M; Prozesky H; Wood R; Johnson LF; Egger M; Boulle A; Myer L;
    PLoS Med; 2012; 9(9):e1001304. PubMed ID: 22973181
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD4+ cell count responses to antiretroviral therapy are not impaired in HIV-infected individuals with tuberculosis co-infection.
    Gupta RK; Brown AE; Zenner D; Rice B; Yin Z; Thomas HL; Pozniak A; Abubakar I; Delpech V; Lipman M
    AIDS; 2015 Jul; 29(11):1363-8. PubMed ID: 26091298
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalent and incident tuberculosis are independent risk factors for mortality among patients accessing antiretroviral therapy in South Africa.
    Gupta A; Wood R; Kaplan R; Bekker LG; Lawn SD
    PLoS One; 2013; 8(2):e55824. PubMed ID: 23418463
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immediate Blood Draw for CD4+ Cell Count Is Associated with Linkage to Care in Durban, South Africa: Findings from Pathways to Engagement in HIV Care.
    Hoffman S; Exner TM; Lince-Deroche N; Leu CS; Phillip JL; Kelvin EA; Gandhi AD; Levin B; Singh D; Mantell JE; Blanchard K; Ramjee G
    PLoS One; 2016; 11(10):e0162085. PubMed ID: 27706150
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Initiating Antiretroviral Therapy for HIV at a Patient's First Clinic Visit: The RapIT Randomized Controlled Trial.
    Rosen S; Maskew M; Fox MP; Nyoni C; Mongwenyana C; Malete G; Sanne I; Bokaba D; Sauls C; Rohr J; Long L
    PLoS Med; 2016 May; 13(5):e1002015. PubMed ID: 27163694
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Initiation of antiretroviral therapy based on the 2015 WHO guidelines.
    Kuznik A; Iliyasu G; Habib AG; Musa BM; Kambugu A; Lamorde M
    AIDS; 2016 Nov; 30(18):2865-2873. PubMed ID: 27662547
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Setting ART initiation targets in response to changing guidelines: The importance of addressing both steady-state and backlog.
    Martin C; Naidoo NP; Venter WD; Jaffer A; Barker PM
    S Afr Med J; 2014 May; 104(6):428-30. PubMed ID: 25214253
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcomes in patients waiting for antiretroviral treatment in the Free State Province, South Africa: prospective linkage study.
    Ingle SM; May M; Uebel K; Timmerman V; Kotze E; Bachmann M; Sterne JA; Egger M; Fairall L;
    AIDS; 2010 Nov; 24(17):2717-25. PubMed ID: 20935554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 69.